Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance

Abstract

In recent years, most cDNA microarray studies of chemotherapeutic drug resistance have not considered the temporal pattern of gene expression. The objective of this study was to examine systematically changes in gene expression of NCI-H226 and NCI-H2170 lung cancer cells treated weekly with IC10 doses of cisplatin. NCI-H226 lung cancer cells were treated weekly with an IC10 dose of cisplatin. Candidate genes with a fold change of 2.0 or more were identified from this study. A second experiment was conducted by exposing NCI-H2170 cells to cisplatin doses that were increased in week 4 and decreased in week 5. Overall, 44 genes were differentially expressed in both the NCI-H226 and NCI-H2170 cell lines. In the NCI-H2170 cell line, 24 genes had a twofold gene expression change from weeks 3 to 4. Real-time PCR found a significant correlation of the gene expression changes for seven genes of interest. This small time-ordered series identified novel genes associated with cisplatin resistance. This kind of analysis should be viewed as a first step towards building gene-regulatory networks.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA and Holt JT . (1999). J. Biol. Chem., 274, 18808–18812.

  • Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC and Fornace Jr AJ . (2000). Cancer Res., 60, 6101–6110.

  • Anderson IC, Sugarbaker DJ, Ganju RK, Tsarwhas DG, Richards WG, Sunday M, Kobzik L and Shipp MA . (1995). Cancer Res., 55, 4120–4126.

  • Anderson KM, Alrefai WA, Anderson CA, Ho Y, Jadko S, Ou D, Wu Y-B and Harris JE . (2002). Anticancer Res., 22, 75–82.

  • Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR and Bishop DK . (2000). J. Biol. Chem., 275, 23899–23903.

  • Bolon I, Devouassoux M, Robert C, Moro D, Brambilla C and Brambilla E . (1997). Am. J. Pathol., 150, 1619–1629.

  • Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM and Breit SN . (1997). Proc. Natl. Acad. Sci. USA, 94, 11514–11519.

  • Boulay A, Masson R, Chenard MP, El Fahime M, Cassard L, Bellocq JP, Sautes-Fridman C, Basset P and Rio MC . (2001). Cancer Res., 61, 2189–2193.

  • Brognard J, Clark AS, Ni Y and Dennis PA . (2001). Cancer Res., 61, 3986–3997.

  • Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S and Nakshatri H . (2001). J. Biol. Chem., 276, 9817–9824.

  • Citri A, Skaria KB and Yarden Y . (2003). Exp. Cell Res., 284, 54–65.

  • Clave E, Carosella ED, Gluckman E and Socie G . (1997). Leukemia, 11, 114–119.

  • Dabholkar M, Bostick-Bruton F, Weber C, Bohr VA, Egwuagu C and Reed E . (1992). J. Natl. Cancer Inst., 84, 1512–1517.

  • Dan S, Tsunoda T, Kitahara O, Yanagawa R, Zembutsu H, Katagiri T, Yamazaki K, Nakamura Y and Yamori T . (2002). Cancer Res., 62, 1139–1147.

  • De Larco JE, Wuertz BR, Manivel JC and Furcht LT . (2001). Cancer Res., 61, 2857–2861.

  • Delebecq TJ, Porte H, Zerimech F, Copin MC, Gouyer V, Dacquembronne E, Balduyck M, Wurtz A and Huet G . (2000). Clin. Cancer Res., 6, 1086–1092.

  • Dunkern TR, Fritz G and Kaina B . (2001). Mutat. Res., 486, 249–258.

  • Henderson YC, Chou M and Deisseroth AB . (1997). Br. J. Haematol., 96, 566–575.

  • Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS and Chin K-V . (2000). Cancer Res., 60, 4161–4166.

  • Lai WW, Chen FF, Wu MH, Chow NH, Su WC, Ma MC, Su PF, Chen H, Lin MY and Tseng YL . (2001). Ann. Thorac. Surg., 72, 1868–1876.

  • Lamendola DE, Duan Z, Yusuf RZ and Seiden MV . (2003). Cancer Res., 63, 2200–2205.

  • Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I and Lee JH . (2003). Cancer Res., 63, 4648–4655.

  • Li Q, Yu JJ, Mu C, Yunmbam MK, Slavsky D, Cross CL, Bostick-Bruton F and Reed E . (2000). Anticancer Res., 20, 645–652.

  • Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, Bittner M, Pretlow T, Elkahloun AG, Trepel JB and Kallioniemi OP . (2001). Oncogene, 20, 6718–6723.

  • Moynahan ME, Chiu JW, Koller BH and Jasin M . (1999). Mol. Cell., 4, 511–518.

  • Munster PN, Marchion DC, Basso AD and Rosen N . (2002). Cancer Res., 62, 3132–3137.

  • Noel AC, Lefebvre O, Maquoi E, VanHoorde L, Chenard MP, Mareel M, Foidart JM, Basset P and Rio MC . (1996). J. Clin. Invest., 97, 1924–1930.

  • Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn Jr PA, Carney D, Minna JD and Mulshine JL . (1996). J. Cell. Biochem., 24 (Suppl.), 32–91.

  • Plumb JA, Milroy R and Kaye SB . (1989). Cancer Res., 49, 4435–4440.

  • Rajeevan MS, Ranamukhaarachchi DG, Vernon SD and Unger ER . (2001). Methods, 25, 443–451.

  • Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO and Weinstein JN . (2000). Nat. Genet., 24, 236–244.

  • Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ and Qin J . (2000). Genes Dev., 14, 927–939.

  • Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, Sutherland RL, Breit SN, Moskaluk CA, Frierson Jr HF and Hampton GM . (2003). Proc. Natl. Acad. Sci. USA, 100, 3410–3415.

  • Zhang J and Byrne CD . (1999). Biochem. J., 337 (Part 2), 231–241.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gary L Johanning.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whiteside, M., Chen, DT., Desmond, R. et al. A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance. Oncogene 23, 744–752 (2004). https://doi.org/10.1038/sj.onc.1207164

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207164

Keywords

This article is cited by

Search

Quick links